Evaluation and validation of dose calculation procedures in patient-specific radionuclide therapy

Therapeutic Applications of Monte Carlo Calculations in Nuclear Medicine

Volumn , Issue , 2002, Pages 262-285

  Ljungberg, Michael ^a   Dewaraja, Yuni ^b   Sgouros, George ^c   Strand, Sven Erik ^a  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 35448947077     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (81)

1. Furhang E E, Chui C S, Kolbert K S, Larson S M and Sgouros G 1997 Implementation of a Monte Carlo dosimetry method for patient-specific internal emitter therapy Med. Phys. 24(7) 1163-72
2. Ljungberg M, Strand S-E and King M A 1998 Monte Carlo Calculation in Nuclear Medicine: Applications in Diagnostic Imaging (Bristol: IOP Publishing)
3. DeVries D J, Moore S C, Zimmerman R E, Friedland B and Lanza R C 1990 Development and validation of a Monte Carlo simulation of photon transport in an Auger camera IEEE Trans. Med. Imag. 4 430-8
4. BairdWH, Frey E C, WangWT and Tsui BMW 2000 Characterization of collimator scatter and penetration response for I-123 imaging J. Nucl. Med. 41(5) 133P
5. Pollard K P, Bice A N, Eary J F, Durack L D and Lewellen T K 1992 A method for imaging therapeutic doses of iodine-131 with a clinical gamma camera J. Nucl. Med. 33 771-6
6. Yanch J C and Dobrzeniecki A B 1993 Monte Carlo simulation in SPECT: complete 3D modeling of source, collimator and tomographic data acquisition IEEE Trans. Nucl. Sci. 40 198-203
7. Zubal I G and Harrell C R 1994 Computerized three-dimensional segmented human anatomy Med. Phys. 21 299-302
8. Dawson T W, Caputa K and Stuchly M A 1997 A comparison of 60Hz uniform magnetic and electric induction in the human body Phys. Med. Biol. 42(12) 2319-29
9. Sjögreen K, Ljungberg M, Wingårdh K, Erlandsson K and Strand S-E 2001 Registration of emission and transmission whole-body scintillation camera images J. Nucl. Med. 42(10) 1563-70
10. Pretorius P H, Xia W, KingMA, Tsui BM, Pan T S and Villegas B J 1997 Evaluation of right and left ventricular volume and ejection fraction using a mathematical cardiac torso phantom J. Nucl. Med. 38(10) 1528-35
11. SegarsWP, Lalush D S and Tsui BMW 2002 Modeling respiratory mechanics in the MCAT and spline-based MCAT phantoms IEEE Trans. Nucl. Sci. 48 89-97
12. SegarsWP 2001 Development of a new dynamic NURBS-based cardiac-torso (NCAT) phantom (University of North Carolina)
13. 131I tumor quantification in radioimmunotherapy using SPECT imaging with an ultra-high-energy collimator: Monte Carlo study J. Nucl. Med. 41(10) 1760-7
14. 131I imaging J. Nucl. Med. 41(1) 123-30
15. Dewaraja Y K, Ljungberg M, Bose A, Majumdar A and Koral K 2002 A parallel Monte Carlo code for planar and SPECT imaging: implementation verification and applications in I-131 SPECT Comp. Meth. Progr. Biomed. 67 115-24
16. Dewaraja Y K, Ljungberg M and Koral K 2001 Monte Carlo evaluation of object shape effects in I-131 SPECT tumor activity quantification Eur. J. Nucl. Med. 28 900-6
17. Moore S C 1998 Design of a collimator for imaging 111-In. In Monte Carlo Calculation in Nuclear Medicine: Applications in Diagnostic Imaging edMLjungberg, S-E Strand and M A King (Bristol: IOP Publishing) pp 183-93
18. DeVries D J, KingMA and Moore S C 1999 Characterization of spectral and spatial distributions of penetration, scatter and lead X-rays in Ga-67 SPECT. Conference Records of the IEEE Medical Imaging Conference (M9-6) pp 1701-10
19. 131I using Monte Carlo simulation J. Nucl. Med. 43 1101-9
20. Furhang E E, Chui C S and Sgouros G A 1996 Monte Carlo approach to patientspecific dosimetry Med. Phys. 23(9) 1523-9
21. Tagesson M, Ljungberg M and Strand S E 1996 A Monte-Carlo program converting activity distributions to absorbed dose distributions in a radionuclide treatment planning system Acta Oncol. 35(3) 367-72
22. Kolbert K S, Sgouros G, Scott A M, Bronstein J E, Malane R A, Zhang J et al. 1997 Implementation and evaluation of patient-specific three-dimensional internal dosimetry J. Nucl. Med. 38(2) 301-8
23. Yoriyaz H, Stabin M and dos Santos A 2001 Monte Carlo MCNP4B-based absorbed dose distribution estimates for patient-specific dosimetry J. Nucl. Med. 42(4) 662-9
24. Yoriyaz H, dos Santos A, Stabin M and Cabezas R 2000 Absorbed fractions in a voxel-based phantom calculated with the MCNP-4B code Med. Phys. 27(7) 1555-62
25. Strand S-E, Jönsson B-A, Ljungberg M and Tennvall J 1993 Radioimmunotherapy dosimetry-a review Acta Oncol. 33 807-17
26. Horowitz Y S 1984 Thermoluminescence dosimetry. In Thermoluminiscence and Thermoluminescent Dosimetry ed Y S Horowitz (Boca Raton, FL: Chemical Rubber Company) pp 43-130
27. Wessels B W and Griffith M H 1986 Miniature thermoluminescent dosimeter absorbed dose measurements in tumor phantom models J. Nucl. Med. 27 1308-14
28. Demidecki A J, Williams L E, Wong Y C, Wessels BW, Yorke E D, StrandhMet al. 1993 Considerations on the calibration of small thermoluminescent dosimeters used for measurement of beta particle absorbed doses in liquid environments Med. Phys. 20(4) 1079-87
29. Strand S-E and Strandh M 1994 Parameters to consider for measurements of absorbed doses in vivo with mini-thermoluminescent dosimeters Cancer 73(3) 985-8
30. Strandh M and Strand S-E 1996 In vivo absorbed dose measurements with mini-TLDs. Parameters affecting the reliability Acta Oncol. 35(6)
31. Martin S, Lisbona A, Richard J, Morteau S, Denizot B and Bardies M 2000 Production of new thermoluminescent mini-dosimeters Phys. Med. Biol. 45(2) 479-94
32. Aissi A and Poston J W 1984 An improved volumetric dosimeter for internal dose verification Health Phys. 46(2) 371-6
33. Skalka M 1971 Biochemical Indicators of Radiation Injury in Man (Vienna: International Atomic Energy Agency)
34. Bender M A and Gooch PC 1962 Types and rates of X-ray-induced chromosome aberrations in human blood irradiated, in vitro Proc. Natl Acad. Sci. USA 48 522-32
35. Chambers K A, Harrington N P, RossWMand Filion L G 1998 Relative alterations in blood mononuclear cell populations reflect radiation injury in mice Cytometry 31(1) 45-52
36. Pantelias G E and Maillie H D 1984 The use of peripheral blood mononuclear cell prematurely condensed chromosomes for biological dosimetry Radiat. Res. 99(1) 140-50
37. Lenarczyk M and Slowikowska M G 1995 The micronucleus assay using peripheral blood reticulocytes from X-ray-exposed mice Mutat. Res. 335(3) 229-34
38. FenechMand Morley A A 1985 Measurement of micronuclei in lymphocytes Mutat. Res. 147(1/2) 29-36
39. Boyd E, BuchananWWand Lennox B 1961 Damage to chromosomes by therapeutic doses of radioiodine Lancet i 977-8
40. M’Kacher R, Schlumberger M, Legal J D, Violot D, Beron-Gaillard N, Gaussen A et al. 1998 Biologic dosimetry in thyroid cancer patients after repeated treatments with iodine-131 J. Nucl. Med. 39(5) 825-9
41. M’Kacher R, Legal J D, Schlumberger M, Voisin P, Aubert B, Gaillard N et al. 1996 Biological dosimetry in patients treated with iodine-131 for differentiated thyroid carcinoma J. Nucl. Med. 37(11) 1860-4
42. Tucker J D, Ramsey M J, Lee D A and Minkler J L 1993 Validation of chromosome painting as a biodosimeter in human peripheral lymphocytes following acute exposure to ionizing radiation in vitro Int. J. Radiat. Biol. 64(1) 27-37
43. Schmid E, Zitzelsberger H, Braselmann H, Gray J W and Bauchinger M 1992 Radiation-induced chromosome aberrations analysed by fluorescence in situ hybridization with a triple combination of composite whole chromosome-specific DNA probes Int. J. Radiat. Biol. 62(6) 673-8
44. 131I therapy Thyroid 7(2) 199-204
45. 131I Radiat. Prot. Dosim. 5 141-9
46. 131I therapy for thyroid cancer Int. J. Radiat. Biol. 69(2) 259-68
47. Watanabe N, Yokoyama K, Kinuya S, Shuke N, Shimizu M, Futatsuya R et al. 1998 Radiotoxicity after iodine-131 therapy for thyroid cancer using the micronucleus assay J. Nucl. Med. 39(3) 436-40
48. Ramirez M J, Surralles J, Galofre P, Creus A and Marcos R 1997 Radioactive iodine induces clastogenic and age-dependent aneugenic effects in lymphocytes of thyroid cancer patients as revealed by interphase FISH Mutagenesis 12(6) 449-55
49. MonsieursMA, Thierens HM, van de Wiele C V, Vral AM, Meirlaen I A, de Winter H A et al. 1999 Estimation of risk based on biological dosimetry for patients treated with radioiodine Nucl. Med. Commun. 20(10) 911-17
50. LivingstonGK, FosterA E and ElsonHR 1993 Effect of in vivo exposure to iodine-131 on the frequency and persistence of micronuclei in human lymphocytes J. Toxicol. Environ. Health 40(2/3) 367-75
51. Lambert V, Thierens H, Monsieurs M, Roncancio C and Laurent C 2001 Translocation frequencies measured in patients one year after radioactive iodine therapy for thyrotoxicosis Int. J. Radiat. Biol. 77(6) 679-85
52. 131I exposure: study in hyperthyroidism patients Mutat. Res. 373(1) 39-45
53. Catena C, Villani P, Nastasi R, Conti D, Righi E, Salerno G et al. 1994 Micronuclei and 3AB-index in patients receiving iodine-131 therapy J. Nucl. Biol. Med. 38(4) 586-93
54. 131I therapy Br. J. Radiol. 50 329-31
55. Goddu S M, Howell RW, Giuliani D C and Rao D V 1998 Biological dosimetry of bone marrow for incorporated yttrium-90 J. Nucl. Med. 39(3) 547-52
56. 32P-orthophosphate: implications for therapy of bone pain and bone metastases J. Nucl. Med. 41(5) 941-51
57. 90Y J. Nucl. Med. 42(1) 162-9
58. Siegel J A, Wessels B, Watson E E, Stabin M, Vriesendorp H M, Bradley E W et al. 1990 Bone marrow dosimetry and toxicity for radioimmunotherapy Antibody Immunocon. Radiopharm. 3 213-33
59. Wong J Y, Wang J, Liu A, Odom-Maryon T, Shively J E, Raubitschek A A et al. 2000 Evaluating changes in stable chromosomal translocation frequency in patients receiving radioimmunotherapy Int. J. Radiat. Oncol. Biol. Phys. 46(3) 599-607
60. Gladstone D J, Lu X Q, Humm J L, Bowman H F and Chin L M 1994 A miniature MOSFET radiation dosimeter probe Med. Phys. 21 1721-8
61. Miller S D and Endres G W 1990 Laser-induced optically stimulated M centre luminescence in LiF Radiat. Prot. Dosim. 33(1) 59-62
62. Strandh M, Johansson J and Strand S E A 2001 BaF(Br, I)Eu dosimeter based on laser induced fluorescence for in in vivo measurements (http://www.doseinfo-radar.com/1-pos.htm)
63. Strandh M, Strand S-E, Johansson J and Malmgren L 2002 Dosimetry based on laser induced fluorescence in LiF for in vivo measurements (http://www.doseinforadar. com/1-pos.htm)
64. Schauer D A, Desrosiers M F, Le F G, Seltzer S M and Links J M 1994 EPR dosimetry of cortical bone and tooth enamel irradiated with X and gamma rays: Study of energy dependence Radiat. Res. 138 1-8
65. Ignatiev E A, Lyubashevskii N M, Shishikina E A and Romanyukha A A 1999 EPR dose reconstruction for bone-seeking 90Sr Appl. Radiat. Isot. 51(2) 151-9
66. Wielopolski L, Maryanski M, Ciesielski B, Forman A, Reinstein L E and Meck A G 1987 Continuous three dimensional radiation dosimetry in tissue equivalent phantoms using electron paramagnetic resonance in L-α-alanine Med. Phys. 14 646-52
67. Olsson S, Lund E and Erickson R 1996 Dose response and fading characteristics of an alanine-agarose gel Appl. Radiat. Isot. 47(11) 1211-17
68. Olsson L E, Bäck S Å J, Magnusson P and Haraldsson P 1998 3D Dosimetry Using Gels and MRI eds J D Hazle and A L Boyer (College Park, American Association of Physicists in Medicine. Imaging in Radiation Therapy) pp 475-504
69. Grönberg T, Persson B and Strand S-E 1977 Experimental evaluation of organ doses from exposure to Tc-99m, I-123 and I-131 Proc. IVth Int. Cong. Int. Radiat. Prot. Assoc. (Paris 1977) pp 493-6
70. 32P Med. Phys. 14 98-104
71. Giap H B, Macey D J, Bayouth J E and Boyer A L 1995 Validation of a dose-point kernel convolution technique for internal dosimetry Phys. Med. Biol. 40(3) 365-81
72. Aschan A C, Toivonen M J, Lampinen J S, Tenhunen M, Kairemo K J A, Korppi-Tommola E T et al. 1999 The use of TL detectors in dosimetry of systemic radiation therapy Acta Oncol. 38(2) 189-96
73. 90Yttrium and 131iodine radioimmunoglobulin therapy of an experimental hepatoma Cancer Res. 49 6383-9
74. Hui T E, Fisher D R, Kuhn J A, Williams L E, Nourigat C, Badger C C et al. 1994 A mouse model for calculating cross-organ beta doses from yttrium-90-labeled immunoconjugates Cancer 73(3) 951-7
75. Strand S E, Strandh M, LjungbergMand Tagesson M 1994 Mini-Tl-dosimeters for in vivo measurements J. Nucl. Med. 35 78P
76. Desrosiers M F, Avila M J, Schauer D A, Coursey B M and Parks N J 1993 Experimental validation of radiopharmaceutical absorbed dose to mineralized bone tissue Appl. Radiat. Isot. 44 459-63
77. Chiou R K, Wessels B W, Woodson M and Limas C 1991 Study of clinical thermoluminescent dosimeters (Cl.TLD) in direct measurement of absorbed dose for radioimmunotherapy Int. J. Radiat. Appl. Instrum. A 42 181-6
78. Leichner P K, Yang N-C, Wessels BW, HawkinsWG, Order S E and Klein J L 1990 Dosimetry and treatment planning in radioimmunotherapy Front. Radiat. Ther. Oncol. 24 109-20
79. El-Ali H H, Strand S-E, Larsson S A, Johnsson C, Palmer J, LjungbergMet al. 2002 A new phantom based on ink jet technique for imaging and dosimetry. In Proceedings of the Seventh International Radiopharmaceutical Dosimetry Symposium, Nashville, TN
80. Larsson S A, Jonsson C, Pagani M, Johansson L and Jacobsson H 2000 A novel phantom design for emission tomography enabling scatter-and attenuation-‘free’ single-photon emission tomography imaging Eur. J. Nucl. Med. 27 131-9
81. Aissi A and Poston J W 1987 Comparison of measured and calculated internal absorbed doses in a heterogenous phantom Phys. Med. Biol. 32 1245-56